Small Cap Feast

14th March 2024

Dish of the day
No Joiners today
Off the menu
No leavers today


Dish Of The Day:


Admissions: 


Delistings: 




Whats baking in the oven?

Potential Initial Public Offerings:


Reverse Takeovers:


Change of Market:


Banquet Buffet

Abingdon Health 9.25p £11.3m (ABDX.L)
The lateral flow contract development and manufacturing organisation announces its unaudited interim results for the six months ended 31 December 2023. Revenue increased 117% to £2.4m (H1 2023: £1.1m). The Adjusted EBITDA loss decreased 47% to £1.2m (H1 2023: £2.2m). Furthermore, reduction in operating loss of 50% to £1.2m (H1 2023: £2.4m). The Board therefore expects that H2 2024 revenue will be significantly improved compared with H1 2024.

CAP-XX 0.0675p £0.5m (CPX.L)
The design and manufacture of supercapacitors and energy management systems provides the following update. Maxwell will be applying to the Court for a further extension of time to lodge an application for a claim of costs against CAP-XX before the end of the current week. To emphasise, this filing is purely procedural and does not substantively impact CAP-XX. Maxwell and CAP-XX have an agreement in principle and are in final negotiations to ensure that this issue and all litigation matters with Maxwell/Tesla are resolved as soon as possible.

ECR Minerals 0.335p £5.4m (ECR.L)
The exploration and development company focused on gold in Australia announces that it has successfully raised, subject only to Admission, £585,000 before expenses through the placing of 195,000,000 new ordinary shares at a price of 0.30p per Placing Share. The Placing Price represents a discount of approximately 30% to the closing middle market price of 0.43p per Ordinary Share on 13 March 2024. The net proceeds from the Placing will be used to advance ECR's projects in Victoria and Queensland during 2024.

Eneraqua Technologies 44p £14.6m (ETP.L)
The provider of energy and water efficiency solutions provides an update on trading for the year ended 31 January 2024. The Company also announces that Iain Richardson will be stepping down from his role as CFO with effect from 31 May 2024 and be replaced on an interim basis by his deputy, James Lamb, the current Group Financial Controller. The Company navigated challenging market conditions during FY24 and expects to report revenues of c.£54m and an adjusted PBT loss in line with consensus forecasts of £6.0m, with a stronger than anticipated cash position at the year end of £6.4m representing a net cash position of £1.2m.

FireAngel Safety Technology 5.5p £16.6m (FA.L)
The developer and supplier of home safety products announces that, following 14 years' service, including three years in her current role, Zoe Fox has resigned as Chief Finance Officer and will be replaced by Adrian Wilding, the Company's Commercial Director, who will assume the role of Chief Finance Officer, both with immediate effect. Zoe is expected to remain within the business until June 2024 to ensure a smooth transition to Adrian and release of the Company's final results for the year ended 31 December 2023.

Frontier IP 42.5p £23.9m (FIPP.L)
A specialist in commercialising intellectual property Company announces its unaudited interim results for the six month period ended 31 December 2023. Pre-tax profit of £1.4m (31 December 2022: pre-tax loss of £0.5m). Cash balances of £2.7m at 31 December 2023 (30 June 2023: £4.6m ; 31 December 2022: £5.8m). Frontier IP faces the future with confidence. There are a number of highly promising developments within the portfolio as companies gain industry traction, scale up and achieve commercial viability.

Orcadian Energy 10p £7.9m (ORCA.L)
The Company yesterday executed an agreement to amend the repayment date in its secured facility agreement with Shell International Trading and Shipping Company Limited. The original repayment date of the STASCO loan of US$1m was 23 August 2023; this had been extended to 13 September 2023 and subsequently to 13 March 2024. The repayment date of the Loan has now been extended to 13 June 2024 to allow time for the proposed sale of an 81.25% interest in Licence P2244 to complete and for discussions with Shell on future financial and marketing arrangements to conclude.

Pressure Technologies 38p £14.7m (PRES.L)
The engineering group announces that Chesterfield Special Cylinders, its wholly owned subsidiary, has been awarded two major contracts, as expected, in the defense and green energy sectors and maintains its outlook for FY24. The Group also provides an update on the sale of the Precision Machined Components division. During the next phase of the process, the Board intends to provide selected potential acquirers with additional access to PMC and will invite final offers for the division.

Smarttech247 25p £28.4m (S247.L)
The provider of AI-enhanced cybersecurity services providing automated managed detection and response for a portfolio of international clients announces it has secured a new contract with a global packaging company, worth approximately €1m over three years. The agreement, with a new client, utilises both Smarttech247's VisionX platform as well as NoPhish, underscoring their versatility and advanced capabilities. The VisionX MDR platform leverages sophisticated AI and machine learning algorithms to offer real-time threat detection, rapid incident response, and continuous monitoring whilst NoPhish takes proactive measures by automatically removing emails from the user's inbox which are deemed suspicious or malicious.

Sylvania Platinum 58.5p £153.8m (SLP.L)
The platinum group metals producer and developer with assets in South Africa announces that the Company has, on 13 March 2024, acquired 130,000 Ordinary Shares of $0.01 each in the Company from the market at an average price of 59.7p per Ordinary Share, placed into Treasury pending cancellation. For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, the Company's issued share capital is 275,375,725 Ordinary Shares. Following the above purchase, a total of 12,595,211 Ordinary Shares, including 830,000 pending cancellation, are held in Treasury. Therefore, the total number of Ordinary Shares with voting rights in Sylvania is 262,780,514 Ordinary Shares.

14 March 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram